MUMBAI (Reuters) - The Nifty fell for a third day on Monday as Ranbaxy recorded its biggest single-day fall after an import alert ban from the U.S. Food and Drug Administration, while faster-than-expected rise in August inflation also weighed.
Ranbaxy Laboratories Ltd provisionally slumped 30 percent to mark its lowest close in nearly one month, while IT shares including Tata Consultancy Services Ltd fell 3 percent as the rupee rose over 1 percent to the dollar.
The Nifty fell 0.07 percent while the Sensex ended 0.05 percent higher. (Reporting by Abhishek Vishnoi; Editing by Anand Basu)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app